NEXT Biometrics Group ASA (NEXT.OL)
NOK 6.5
(0.0%)
NOK 6.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -56.26 Million | -32.37 Million | -47.68 Million | -80.36 Million | -131.39 Million | -144.41 Million |
| Net Income | -65.73 Million | -46.39 Million | -58.39 Million | -104.78 Million | -164.31 Million | -171.31 Million |
| Depreciation & Amortization | 7.06 Million | 7.22 Million | 7.06 Million | 15.27 Million | 16.8 Million | 10.02 Million |
| Deferred income taxes | -20.03 Million | - | - | - | - | - |
| Stock-based compensation | 10.5 Million | 2.07 Million | 13.01 Million | 4.44 Million | 2.89 Million | 11.93 Million |
| Change in working capital | -13.49 Million | 4.71 Million | -18 Million | -1.4 Million | 15.36 Million | 6.88 Million |
| Other non-cash items | 30.03 Million | 6000.00 | 8.63 Million | 6.16 Million | -2.14 Million | -1.93 Million |
| Investing Cash Flow | -45 Thousand | 626 Thousand | 489 Thousand | 40 Thousand | -1.19 Million | -4.13 Million |
| Investments in PPE | -45 Thousand | -70 Thousand | -204 Thousand | -88 Thousand | -1.19 Million | -4.13 Million |
| Acquisitions | - | - | 2000.00 | 11 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 696 Thousand | 691 Thousand | 117 Thousand | - | 1000.00 |
| Financing Cash Flow | 54.93 Million | -2 Million | 83.26 Million | 61.29 Million | 174.51 Million | 114.42 Million |
| Debt repayment | -2.07 Million | -2.73 Million | -626 Thousand | -10.15 Million | -4.23 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 57.01 Million | 738 Thousand | 86.68 Million | 55.72 Million | 178.75 Million | 114.42 Million |
| Other Financing Activities | 57.01 Million | -2.73 Million | -2.78 Million | 15.72 Million | -4.23 Million | 114.42 Million |
| Accounts receivables | -6.04 Million | 5.54 Million | -7.74 Million | -575 Thousand | 12.74 Million | 5.08 Million |
| Accounts payables | -1.79 Million | 990 Thousand | -4.26 Million | -740 Thousand | -7.31 Million | -2.53 Million |
| Inventory | -190 Thousand | -3.94 Million | 2.73 Million | 4.23 Million | 3.41 Million | -1.35 Million |
| Other working capital | -13.49 Million | 2.13 Million | -8.73 Million | -4.32 Million | 6.52 Million | 8.23 Million |
| Cash at beginning of period | 69.3 Million | 102.7 Million | 67.95 Million | 88.54 Million | 46.29 Million | 79.72 Million |
| Cash at end of period | 67.75 Million | 69.3 Million | 102.7 Million | 67.95 Million | 88.54 Million | 46.29 Million |
| Capital Expenditure | -45 Thousand | -70 Thousand | -204 Thousand | -88 Thousand | -1.19 Million | -4.13 Million |
| Effect of forex changes on cash | -178 Thousand | 347 Thousand | -1.32 Million | -1.55 Million | 315 Thousand | 708 Thousand |
| Net cash flow / Change in cash | -1.55 Million | -33.4 Million | 34.75 Million | -20.59 Million | 42.24 Million | -33.42 Million |
| Free Cash Flow | -56.3 Million | -32.44 Million | -47.88 Million | -80.45 Million | -132.59 Million | -148.55 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.05 Million | -15.48 Million | -12.15 Million | -65.73 Million | -20.38 Million | -18.71 Million |
| Depreciation & Amortization | 1.53 Million | 1.52 Million | 1.54 Million | 7.06 Million | 1.69 Million | 1.94 Million |
| Deferred income taxes | - | - | -5.81 Million | -20.03 Million | - | - |
| Stock-based compensation | -1.73 Million | 5.02 Million | 2.72 Million | 10.5 Million | 3.02 Million | 4.24 Million |
| Change in working capital | -7.72 Million | -5.33 Million | -10.76 Million | -13.49 Million | 1.3 Million | -1.04 Million |
| Other non-cash items | 1.3 Million | 8.16 Million | 5.95 Million | 30.03 Million | 5.17 Million | -70 Thousand |
| Investing Cash Flow | -12 Thousand | - | -45 Thousand | -45 Thousand | -1000.00 | -1000.00 |
| Investments in PPE | -12 Thousand | - | -45 Thousand | -45 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 46 Thousand | 1.54 Million | -446 Thousand | 54.93 Million | 56.4 Million | -475 Thousand |
| Debt repayment | - | -533 Thousand | -528 Thousand | -2.07 Million | -511 Thousand | -492 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 597 Thousand | 2.07 Million | 82 Thousand | 57.01 Million | 56.91 Million | 17 Thousand |
| Other Financing Activities | -551 Thousand | 1000.00 | 82 Thousand | 57.01 Million | -510 Thousand | -492 Thousand |
| Accounts receivables | - | - | -6.04 Million | -6.04 Million | - | - |
| Accounts payables | - | - | - | -1.79 Million | - | - |
| Inventory | - | - | -190 Thousand | -190 Thousand | - | - |
| Other working capital | -7.72 Million | -5.33 Million | -10.76 Million | -13.49 Million | 1.3 Million | -1.04 Million |
| Cash at beginning of period | 54.56 Million | 67.75 Million | 86.15 Million | 69.3 Million | 38.62 Million | 53.01 Million |
| Cash at end of period | 40.87 Million | 54.56 Million | 67.75 Million | 67.75 Million | 86.15 Million | 38.62 Million |
| Capital Expenditure | -12 Thousand | - | -45 Thousand | -45 Thousand | - | - |
| Effect of forex changes on cash | 281 Thousand | -539 Thousand | 597 Thousand | -178 Thousand | 307 Thousand | -264 Thousand |
| Net cash flow / Change in cash | -13.69 Million | -13.18 Million | -18.39 Million | -1.55 Million | 47.52 Million | -14.38 Million |
| Free Cash Flow | -14.02 Million | -14.18 Million | -18.54 Million | -56.3 Million | -9.18 Million | -13.64 Million |
601188
CCE
ALV
REP
688248
300428